Life Sciences, Exits

Lab 901

Lab 901 was sold to Agilent Technologies, a US listed company, in 2011. The original investment by Archangels was made in 2002.

Lab901’s revolutionary ScreenTape product automates a traditional bio-analysis process used by thousands of scientists and clinicians around the world. ScreenTape enables diagnostic and life science research labs to achieve rapid and accurate results effortlessly and is now sold across 5 continents.

Year of exit


Seeking investment?

Our team is always actively seeking new investment opportunities. They review circa 200 business plans each year.

Become a member

Our members are genuinely motivated to give something back and build great businesses in Scotland, as well as making a financial return.

We use cookies to give you the best experience. Cookie Policy

Preloader image